Briefing: Trump's Drug Pricing Moves and GSK Asthma Drug Insights
Strategic angle: The White House intensifies pressure on Congress for drug pricing legislation.
Editorial Staff
1 min read
Updated 4 months ago
Focus on 'most-favored nation' drug pricing policy.
GSK's new asthma drug developments.
Impact of legislative changes on pharmaceutical industry.